Associate Director, Regulatory Affairs Advertising and Promotion
Gilead SciencesSalary not specified
- Full Time
- Expert & Leadership (9+ years)
Eli Lilly and Company
Sr. Director - GRA, Global Regulatory Policy & Strategy - Oncology
$200,000 – $300,000Compensation
Senior (5 to 8 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Biotechnology, HealthcareIndustries
Requirements
Candidates should possess a Bachelor’s degree in a relevant scientific or technical field, and ideally hold a Ph.D. or equivalent advanced degree. Significant experience in regulatory affairs, particularly within the pharmaceutical or biotechnology industry, is required, along with a strong understanding of global regulatory landscapes and oncology drug development. Proven ability to develop and execute regulatory strategies and build external relationships is essential.
Responsibilities
The Sr. Director – GRA will establish regulatory policy positions and external engagement strategies, critically review regulatory proposals, articulate challenges, and identify data to support company positions in collaboration with cross-functional teams. They will cultivate relationships with internal and external stakeholders, engage in health-policy forums, and represent Lilly at industry conferences to influence policy and ultimately impact patient outcomes through collaboration.
Skills
Regulatory Affairs
Global Regulatory Landscapes
Oncology Drug Development
Regulatory Strategy
Stakeholder Management
Health Policy
External Engagement
Eli Lilly and Company
Develops and delivers prescription medicines globally
About Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.
Key Metrics
Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees